---
keywords:
  - VIOLA-AI Intracranial Hemorrhage Model
  - NeoMedSys Platform
  - Intracranial Hemorrhage Detection
  - Real-Time Feedback in AI Model Training
category: cs.AI
publish_date: 2025-09-22
arxiv_id: 2505.09380
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-23T09:56:05.407162",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "VIOLA-AI Intracranial Hemorrhage Model",
    "NeoMedSys Platform",
    "Intracranial Hemorrhage Detection",
    "Real-Time Feedback in AI Model Training"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "VIOLA-AI Intracranial Hemorrhage Model": 0.88,
    "NeoMedSys Platform": 0.82,
    "Intracranial Hemorrhage Detection": 0.8,
    "Real-Time Feedback in AI Model Training": 0.77
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "VIOLA-AI",
        "canonical": "VIOLA-AI Intracranial Hemorrhage Model",
        "aliases": [
          "VIOLA-AI"
        ],
        "category": "unique_technical",
        "rationale": "This model is central to the study and offers unique insights into AI applications in medical imaging.",
        "novelty_score": 0.85,
        "connectivity_score": 0.65,
        "specificity_score": 0.9,
        "link_intent_score": 0.88
      },
      {
        "surface": "NeoMedSys",
        "canonical": "NeoMedSys Platform",
        "aliases": [
          "NeoMedSys"
        ],
        "category": "unique_technical",
        "rationale": "The platform is crucial for deploying and refining AI models, providing a unique context for AI integration in healthcare.",
        "novelty_score": 0.8,
        "connectivity_score": 0.7,
        "specificity_score": 0.85,
        "link_intent_score": 0.82
      },
      {
        "surface": "intracranial hemorrhage",
        "canonical": "Intracranial Hemorrhage Detection",
        "aliases": [
          "ICH Detection"
        ],
        "category": "specific_connectable",
        "rationale": "This medical condition is the primary focus of the AI model, linking AI technology to clinical outcomes.",
        "novelty_score": 0.55,
        "connectivity_score": 0.78,
        "specificity_score": 0.88,
        "link_intent_score": 0.8
      },
      {
        "surface": "real-time radiologist feedback",
        "canonical": "Real-Time Feedback in AI Model Training",
        "aliases": [
          "Radiologist Feedback"
        ],
        "category": "evolved_concepts",
        "rationale": "Incorporating real-time feedback is a novel approach to improving AI model accuracy and relevance.",
        "novelty_score": 0.75,
        "connectivity_score": 0.72,
        "specificity_score": 0.8,
        "link_intent_score": 0.77
      }
    ],
    "ban_list_suggestions": [
      "AI tools",
      "performance metrics",
      "clinical settings",
      "model retraining"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "VIOLA-AI",
      "resolved_canonical": "VIOLA-AI Intracranial Hemorrhage Model",
      "decision": "linked",
      "scores": {
        "novelty": 0.85,
        "connectivity": 0.65,
        "specificity": 0.9,
        "link_intent": 0.88
      }
    },
    {
      "candidate_surface": "NeoMedSys",
      "resolved_canonical": "NeoMedSys Platform",
      "decision": "linked",
      "scores": {
        "novelty": 0.8,
        "connectivity": 0.7,
        "specificity": 0.85,
        "link_intent": 0.82
      }
    },
    {
      "candidate_surface": "intracranial hemorrhage",
      "resolved_canonical": "Intracranial Hemorrhage Detection",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.78,
        "specificity": 0.88,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "real-time radiologist feedback",
      "resolved_canonical": "Real-Time Feedback in AI Model Training",
      "decision": "linked",
      "scores": {
        "novelty": 0.75,
        "connectivity": 0.72,
        "specificity": 0.8,
        "link_intent": 0.77
      }
    }
  ]
}
-->

# Examining Deployment and Refinement of the VIOLA-AI Intracranial Hemorrhage Model Using an Interactive NeoMedSys Platform

**Korean Title:** VIOLA-AI ë‘ê°œë‚´ ì¶œí˜ˆ ëª¨ë¸ì˜ ë°°ì¹˜ ë° ê°œì„ ì„ ëŒ€í™”í˜• NeoMedSys í”Œë«í¼ì„ ì‚¬ìš©í•˜ì—¬ ê²€í† í•˜ê¸°

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250922|20250922]] [[categories/cs.AI|cs.AI]]
**PDF**: [Download](https://arxiv.org/pdf/2505.09380.pdf)
**Category**: cs.AI
**Published**: 2025-09-22
**ArXiv ID**: [2505.09380](https://arxiv.org/abs/2505.09380)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-22/From Development to Deployment of AI-assisted Telehealth and Screening for Vision- and Hearing-threatening diseases in resource-constrained settings_ Field Observations, Challenges and Way Forward_20250922|From Development to Deployment of AI-assisted Telehealth and Screening for Vision- and Hearing-threatening diseases in resource-constrained settings: Field Observations, Challenges and Way Forward]] (81.3% similar)
- [[2025-09-22/Temperature-Driven Robust Disease Detection in Brain and Gastrointestinal Disorders via Context-Aware Adaptive Knowledge Distillation_20250922|Temperature-Driven Robust Disease Detection in Brain and Gastrointestinal Disorders via Context-Aware Adaptive Knowledge Distillation]] (81.2% similar)
- [[2025-09-19/Mixture of Multicenter Experts in Multimodal AI for Debiased Radiotherapy Target Delineation_20250919|Mixture of Multicenter Experts in Multimodal AI for Debiased Radiotherapy Target Delineation]] (80.9% similar)
- [[2025-09-22/Data-Efficient Learning for Generalizable Surgical Video Understanding_20250922|Data-Efficient Learning for Generalizable Surgical Video Understanding]] (80.7% similar)
- [[2025-09-18/ProtoMedX_ Towards Explainable Multi-Modal Prototype Learning for Bone Health Classification_20250918|ProtoMedX: Towards Explainable Multi-Modal Prototype Learning for Bone Health Classification]] (80.6% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”— Specific Connectable**: [[keywords/Intracranial Hemorrhage Detection|Intracranial Hemorrhage Detection]]
**âš¡ Unique Technical**: [[keywords/VIOLA-AI Intracranial Hemorrhage Model|VIOLA-AI Intracranial Hemorrhage Model]], [[keywords/NeoMedSys Platform|NeoMedSys Platform]]
**ğŸš€ Evolved Concepts**: [[keywords/Real-Time Feedback in AI Model Training|Real-Time Feedback in AI Model Training]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2505.09380v2 Announce Type: replace-cross 
Abstract: Background: There are many challenges and opportunities in the clinical deployment of AI tools in radiology. The current study describes a radiology software platform called NeoMedSys that can enable efficient deployment and refinements of AI models. We evaluated the feasibility and effectiveness of running NeoMedSys for three months in real-world clinical settings and focused on improvement performance of an in-house developed AI model (VIOLA-AI) designed for intracranial hemorrhage (ICH) detection.
  Methods: NeoMedSys integrates tools for deploying, testing, and optimizing AI models with a web-based medical image viewer, annotation system, and hospital-wide radiology information systems. A prospective pragmatic investigation was deployed using clinical cases of patients presenting to the largest Emergency Department in Norway (site-1) with suspected traumatic brain injury (TBI) or patients with suspected stroke (site-2). We assessed ICH classification performance as VIOLA-AI encountered new data and underwent pre-planned model retraining. Performance metrics included sensitivity, specificity, accuracy, and the area under the receiver operating characteristic curve (AUC).
  Results: NeoMedSys facilitated iterative improvements in the AI model, significantly enhancing its diagnostic accuracy. Automated bleed detection and segmentation were reviewed in near real-time to facilitate re-training VIOLA-AI. The iterative refinement process yielded a marked improvement in classification sensitivity, rising to 90.3% (from 79.2%), and specificity that reached 89.3% (from 80.7%). The bleed detection ROC analysis for the entire sample demonstrated a high area-under-the-curve (AUC) of 0.949 (from 0.873). Model refinement stages were associated with notable gains, highlighting the value of real-time radiologist feedback.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

arXiv:2505.09380v2 ë°œí‘œ ìœ í˜•: êµì°¨ êµì²´  
ì´ˆë¡: ë°°ê²½: ë°©ì‚¬ì„ í•™ì—ì„œ AI ë„êµ¬ì˜ ì„ìƒ ë°°ì¹˜ì—ëŠ” ë§ì€ ë„ì „ê³¼ ê¸°íšŒê°€ ìˆìŠµë‹ˆë‹¤. í˜„ì¬ ì—°êµ¬ëŠ” AI ëª¨ë¸ì˜ íš¨ìœ¨ì ì¸ ë°°ì¹˜ì™€ ê°œì„ ì„ ê°€ëŠ¥í•˜ê²Œ í•˜ëŠ” NeoMedSysë¼ëŠ” ë°©ì‚¬ì„ í•™ ì†Œí”„íŠ¸ì›¨ì–´ í”Œë«í¼ì„ ì„¤ëª…í•©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ì‹¤ì œ ì„ìƒ í™˜ê²½ì—ì„œ NeoMedSysë¥¼ 3ê°œì›” ë™ì•ˆ ìš´ì˜í•˜ëŠ” ê²ƒì˜ ì‹¤í–‰ ê°€ëŠ¥ì„±ê³¼ íš¨ê³¼ë¥¼ í‰ê°€í–ˆìœ¼ë©°, ë‘ê°œë‚´ ì¶œí˜ˆ(ICH) íƒì§€ë¥¼ ìœ„í•´ ìì²´ ê°œë°œí•œ AI ëª¨ë¸(VIOLA-AI)ì˜ ì„±ëŠ¥ ê°œì„ ì— ì¤‘ì ì„ ë‘ì—ˆìŠµë‹ˆë‹¤.  
ë°©ë²•: NeoMedSysëŠ” ì›¹ ê¸°ë°˜ ì˜ë£Œ ì´ë¯¸ì§€ ë·°ì–´, ì£¼ì„ ì‹œìŠ¤í…œ ë° ë³‘ì› ì „ì²´ ë°©ì‚¬ì„  ì •ë³´ ì‹œìŠ¤í…œê³¼ í•¨ê»˜ AI ëª¨ë¸ì„ ë°°í¬, í…ŒìŠ¤íŠ¸ ë° ìµœì í™”í•˜ê¸° ìœ„í•œ ë„êµ¬ë¥¼ í†µí•©í•©ë‹ˆë‹¤. ë…¸ë¥´ì›¨ì´ì—ì„œ ê°€ì¥ í° ì‘ê¸‰ì‹¤(site-1)ì— ì™¸ìƒì„± ë‡Œ ì†ìƒ(TBI)ì´ ì˜ì‹¬ë˜ëŠ” í™˜ì ë˜ëŠ” ë‡Œì¡¸ì¤‘ì´ ì˜ì‹¬ë˜ëŠ” í™˜ì(site-2)ì˜ ì„ìƒ ì‚¬ë¡€ë¥¼ ì‚¬ìš©í•˜ì—¬ ì „í–¥ì  ì‹¤ìš©ì  ì¡°ì‚¬ê°€ ë°°ì¹˜ë˜ì—ˆìŠµë‹ˆë‹¤. VIOLA-AIê°€ ìƒˆë¡œìš´ ë°ì´í„°ë¥¼ ì ‘í•˜ê³  ì‚¬ì „ ê³„íšëœ ëª¨ë¸ ì¬í›ˆë ¨ì„ ê±°ì¹˜ë©´ì„œ ICH ë¶„ë¥˜ ì„±ëŠ¥ì„ í‰ê°€í–ˆìŠµë‹ˆë‹¤. ì„±ëŠ¥ ì§€í‘œì—ëŠ” ë¯¼ê°ë„, íŠ¹ì´ë„, ì •í™•ë„ ë° ìˆ˜ì‹ ì ì‘ë™ íŠ¹ì„± ê³¡ì„  ì•„ë˜ ë©´ì (AUC)ì´ í¬í•¨ë˜ì—ˆìŠµë‹ˆë‹¤.  
ê²°ê³¼: NeoMedSysëŠ” AI ëª¨ë¸ì˜ ë°˜ë³µì ì¸ ê°œì„ ì„ ì´‰ì§„í•˜ì—¬ ì§„ë‹¨ ì •í™•ì„±ì„ í¬ê²Œ í–¥ìƒì‹œì¼°ìŠµë‹ˆë‹¤. ìë™ ì¶œí˜ˆ íƒì§€ ë° ë¶„í• ì€ VIOLA-AIì˜ ì¬í›ˆë ¨ì„ ì´‰ì§„í•˜ê¸° ìœ„í•´ ê±°ì˜ ì‹¤ì‹œê°„ìœ¼ë¡œ ê²€í† ë˜ì—ˆìŠµë‹ˆë‹¤. ë°˜ë³µì ì¸ ê°œì„  ê³¼ì •ì€ ë¶„ë¥˜ ë¯¼ê°ë„ì˜ í˜„ì €í•œ í–¥ìƒì„ ê°€ì ¸ì™”ìœ¼ë©°, 90.3% (79.2%ì—ì„œ ìƒìŠ¹)ë¡œ ì¦ê°€í–ˆê³ , íŠ¹ì´ë„ëŠ” 89.3% (80.7%ì—ì„œ ìƒìŠ¹)ì— ë„ë‹¬í–ˆìŠµë‹ˆë‹¤. ì „ì²´ ìƒ˜í”Œì— ëŒ€í•œ ì¶œí˜ˆ íƒì§€ ROC ë¶„ì„ì€ 0.949 (0.873ì—ì„œ ìƒìŠ¹)ì˜ ë†’ì€ ê³¡ì„  ì•„ë˜ ë©´ì (AUC)ì„ ë³´ì—¬ì£¼ì—ˆìŠµë‹ˆë‹¤. ëª¨ë¸ ê°œì„  ë‹¨ê³„ëŠ” ì‹¤ì‹œê°„ ë°©ì‚¬ì„  ì „ë¬¸ì˜ í”¼ë“œë°±ì˜ ê°€ì¹˜ë¥¼ ê°•ì¡°í•˜ë©´ì„œ ì£¼ëª©í•  ë§Œí•œ ì´ìµê³¼ ê´€ë ¨ì´ ìˆì—ˆìŠµë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ì´ ì—°êµ¬ëŠ” ë°©ì‚¬ì„ í•™ì—ì„œ AI ë„êµ¬ì˜ ì„ìƒ ë°°ì¹˜ë¥¼ ìœ„í•œ ì†Œí”„íŠ¸ì›¨ì–´ í”Œë«í¼ NeoMedSysë¥¼ ì†Œê°œí•˜ê³ , ì´ë¥¼ í†µí•´ AI ëª¨ë¸ì˜ íš¨ìœ¨ì ì¸ ë°°ì¹˜ì™€ ê°œì„ ì„ ê°€ëŠ¥í•˜ê²Œ í•©ë‹ˆë‹¤. ì—°êµ¬ëŠ” 3ê°œì›” ë™ì•ˆ ì‹¤ì œ ì„ìƒ í™˜ê²½ì—ì„œ NeoMedSysì˜ ì‹¤í–‰ ê°€ëŠ¥ì„±ê³¼ íš¨ê³¼ë¥¼ í‰ê°€í–ˆìœ¼ë©°, ë‘ê°œë‚´ ì¶œí˜ˆ(ICH) ê°ì§€ë¥¼ ìœ„í•œ ìì²´ ê°œë°œ AI ëª¨ë¸(VIOLA-AI)ì˜ ì„±ëŠ¥ ê°œì„ ì— ì¤‘ì ì„ ë‘ì—ˆìŠµë‹ˆë‹¤. NeoMedSysëŠ” AI ëª¨ë¸ì˜ ë°°í¬, í…ŒìŠ¤íŠ¸, ìµœì í™”ë¥¼ ìœ„í•œ ë„êµ¬ì™€ ì›¹ ê¸°ë°˜ ì˜ë£Œ ì´ë¯¸ì§€ ë·°ì–´, ì£¼ì„ ì‹œìŠ¤í…œ, ë³‘ì› ì „ì²´ ë°©ì‚¬ì„  ì •ë³´ ì‹œìŠ¤í…œì„ í†µí•©í•©ë‹ˆë‹¤. ì—°êµ¬ ê²°ê³¼, NeoMedSysëŠ” AI ëª¨ë¸ì˜ ì§„ë‹¨ ì •í™•ë„ë¥¼ í¬ê²Œ í–¥ìƒì‹œì¼°ìœ¼ë©°, VIOLA-AIì˜ ë¶„ë¥˜ ë¯¼ê°ë„ëŠ” 79.2%ì—ì„œ 90.3%ë¡œ, íŠ¹ì´ë„ëŠ” 80.7%ì—ì„œ 89.3%ë¡œ ê°œì„ ë˜ì—ˆìŠµë‹ˆë‹¤. ë˜í•œ, ì „ì²´ ìƒ˜í”Œì— ëŒ€í•œ ROC ë¶„ì„ì—ì„œ AUCê°€ 0.873ì—ì„œ 0.949ë¡œ ì¦ê°€í•˜ì—¬ ì‹¤ì‹œê°„ ë°©ì‚¬ì„  ì „ë¬¸ì˜ í”¼ë“œë°±ì˜ ê°€ì¹˜ë¥¼ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. NeoMedSysëŠ” AI ëª¨ë¸ì˜ íš¨ìœ¨ì ì¸ ë°°í¬ì™€ ê°œì„ ì„ ì§€ì›í•˜ëŠ” ë°©ì‚¬ì„ í•™ ì†Œí”„íŠ¸ì›¨ì–´ í”Œë«í¼ì…ë‹ˆë‹¤.
- 2. NeoMedSysëŠ” ì›¹ ê¸°ë°˜ ì˜ë£Œ ì´ë¯¸ì§€ ë·°ì–´, ì£¼ì„ ì‹œìŠ¤í…œ, ë³‘ì› ì „ì²´ ë°©ì‚¬ì„  ì •ë³´ ì‹œìŠ¤í…œê³¼ í†µí•©ë©ë‹ˆë‹¤.
- 3. VIOLA-AI ëª¨ë¸ì˜ ICH ë¶„ë¥˜ ì„±ëŠ¥ì€ ìƒˆë¡œìš´ ë°ì´í„°ì™€ ê³„íšëœ ëª¨ë¸ ì¬í›ˆë ¨ì„ í†µí•´ ê°œì„ ë˜ì—ˆìŠµë‹ˆë‹¤.
- 4. NeoMedSysë¥¼ í†µí•œ ë°˜ë³µì ì¸ ê°œì„  ê³¼ì •ì€ VIOLA-AIì˜ ì§„ë‹¨ ì •í™•ë„ë¥¼ í¬ê²Œ í–¥ìƒì‹œì¼°ìŠµë‹ˆë‹¤.
- 5. ëª¨ë¸ ê°œì„  ê³¼ì •ì—ì„œ ë¯¼ê°ë„ëŠ” 90.3%ë¡œ, íŠ¹ì´ë„ëŠ” 89.3%ë¡œ ì¦ê°€í–ˆìœ¼ë©°, AUCëŠ” 0.949ë¡œ ë†’ì•„ì¡ŒìŠµë‹ˆë‹¤.


---

*Generated on 2025-09-23 09:56:05*